Symbol="RPRX"
AssetType="Common Stock"
Name="Royalty PharmaÂ Plc"
Description="Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York."
CIK="1802768"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="110 EAST 59TH STREET, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="13450452000"
EBITDA="1183564000"
PERatio="41.11"
PEGRatio="-0.02"
BookValue="13.28"
DividendPerShare="0.77"
DividendYield="0.027"
EPS="0.73"
RevenuePerShareTTM="5.35"
ProfitMargin="0.141"
OperatingMarginTTM="0.501"
ReturnOnAssetsTTM="0.0429"
ReturnOnEquityTTM="0.0612"
RevenueTTM="2359137000"
GrossProfitTTM="1332971000"
DilutedEPSTTM="0.73"
QuarterlyEarningsGrowthYOY="5.41"
QuarterlyRevenueGrowthYOY="0.217"
AnalystTargetPrice="51.35"
TrailingPE="41.11"
ForwardPE="10.85"
PriceToSalesRatioTTM="8.14"
PriceToBookRatio="2.994"
EVToRevenue="10.37"
EVToEBITDA="21.32"
Beta="0.382"
num_52WeekHigh="43.97"
num_52WeekLow="29.2"
num_50DayMovingAverage="32.87"
num_200DayMovingAverage="37.57"
SharesOutstanding="448199000"
DividendDate="2023-06-15"
ExDividendDate="2023-05-18"
symbol="RPRX"
open="30.40"
high="30.50"
low="29.93"
price="30.01"
volume="1616657.00"
latest_trading_day="2023-07-07"
previous_close="30.49"
change="-0.48"
change_percent="-1.5743%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="2212312"
Change_recent_avg="-0.11"
Delta_recent_avg="0.68"
Variance_recent_avg="0.34"
Change_ratio_recent_avg="-0.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="151"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0025.jpeg"
image_negative_thumbnail_id_2="1104"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0137.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="553"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_positive_thumbnail_id_1="672"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_positive_thumbnail_id_2="635"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0073.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
